v3.26.1
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Apr. 24, 2026
Apr. 25, 2025
Apr. 26, 2024
Income Statement [Abstract]      
Net sales $ 36,364 $ 33,537 $ 32,364
Costs and expenses:      
Cost of products sold, excluding amortization of intangible assets 12,721 11,632 11,216
Research and development expense 2,873 2,732 2,735
Selling, general, and administrative expense 11,784 10,849 10,736
Amortization of intangible assets 1,772 1,807 1,693
Restructuring charges, net 249 267 226
Certain litigation charges, net 113 317 149
Other operating expense (income), net 386 (23) 464
Operating profit 6,467 5,955 5,144
Other non-operating expense (income), net (384) (402) (412)
Interest expense, net 715 729 719
Income before income taxes 6,136 5,628 4,837
Income tax provision 1,299 936 1,133
Net income 4,837 4,691 3,705
Net income attributable to noncontrolling interests (37) (29) (28)
Net income attributable to Medtronic $ 4,801 $ 4,662 $ 3,676
Basic earnings per share (in dollars per share) $ 3.75 $ 3.63 $ 2.77
Diluted earnings per share (in dollars per share) $ 3.73 $ 3.61 $ 2.76
Basic weighted average shares outstanding (in shares) 1,281.8 1,285.6 1,327.7
Diluted weighted average shares outstanding (in shares) 1,288.1 1,289.9 1,330.2